Implementing Long-Acting Novel Antiretrovirals

CompletedOBSERVATIONAL
Enrollment

114

Participants

Timeline

Start Date

July 18, 2022

Primary Completion Date

December 22, 2023

Study Completion Date

December 22, 2023

Conditions
Human Immunodeficiency Viruses
Interventions
OTHER

The Feasibility of Intervention Measure (FIM) and Acceptability of Intervention Measure (AIM)

The Feasibility and Acceptability of Intervention Measure (FIM and AIM) are used to evaluate the feasibilit and acceptability of our implementation strategies. The FIM and AIM is a validated implementation outcome measure where higher scores indicate greater feasibility and acceptability

Trial Locations (6)

BN2 1DH

Brighton and Sussex University Hospitals NHS Trust, Brighton

L7 8XP

Royal Liverpool University Hospital, Liverpool

E1 2AT

Blizard Institute, London

NW3 2QG

Royal Free Hospital NHS, London

SE1 7EH

Guys' and St Thomas' NHS Trust, London

SW10 9NH

Chelsea & Westminster NHS Foundation Trust, London

All Listed Sponsors
collaborator

Chelsea and Westminster NHS Foundation Trust

OTHER

collaborator

Barts & The London NHS Trust

OTHER

collaborator

Guy's and St Thomas' NHS Foundation Trust

OTHER

collaborator

Royal Free Hospital NHS Foundation Trust

OTHER

collaborator

Liverpool University Hospitals NHS Foundation Trust

OTHER_GOV

collaborator

Brighton and Sussex University Hospitals NHS Trust

OTHER

lead

Queen Mary University of London

OTHER